157 related articles for article (PubMed ID: 31870729)
21. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
Hung J; Shen S; De Los Santos JF; Kim RY
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
[TBL] [Abstract][Full Text] [Related]
22. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
[TBL] [Abstract][Full Text] [Related]
23. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
24. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
[TBL] [Abstract][Full Text] [Related]
25. Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: a retrospective study.
Kamrava M; Chung MP; Demarco J; Kayode O; Park SJ; Borja L; Chow L; Lee SP; Steinberg ML; Demanes DJ
Brachytherapy; 2013; 12(2):141-7. PubMed ID: 22748291
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
Fanning J; Hoffman ML; Andrews SJ; Harrah AW; Feldmeier JJ
Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
[TBL] [Abstract][Full Text] [Related]
27. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the relationship between vaginal apex "dog ears" and patterns of recurrence in endometrial cancer following adjuvant image guided vaginal cuff brachytherapy.
Venner EK; Ward KA; Wages NA; Walker B; Libby BP; Showalter TN; Romano KD
Brachytherapy; 2023; 22(2):139-145. PubMed ID: 36414525
[TBL] [Abstract][Full Text] [Related]
29. [Brachytherapy for endometrial cancers].
Charra-Brunaud C; Mazeron R
Cancer Radiother; 2013 Apr; 17(2):106-10. PubMed ID: 23375394
[TBL] [Abstract][Full Text] [Related]
30. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma.
Jordan SE; Micaily I; Hernandez E; Ferriss JS; Miyamoto CT; Li S; Micaily B
Brachytherapy; 2017; 16(6):1144-1151. PubMed ID: 28958736
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric impact of cylinder size in high-dose rate vaginal cuff brachytherapy (VCBT) for primary endometrial cancer.
Zhang H; Gopalakrishnan M; Lee P; Kang Z; Sathiaseelan V
J Appl Clin Med Phys; 2016 Sep; 17(5):262-272. PubMed ID: 27685113
[TBL] [Abstract][Full Text] [Related]
32. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.
Boyle JM; Craciunescu O; Steffey B; Cai J; Chino J
Brachytherapy; 2014; 13(4):332-6. PubMed ID: 24439964
[TBL] [Abstract][Full Text] [Related]
33. The role of vaginal cuff brachytherapy in endometrial cancer.
Harkenrider MM; Block AM; Siddiqui ZA; Small W
Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
[TBL] [Abstract][Full Text] [Related]
34. The dosimetric impact of air in vaginal vault brachytherapy.
Maxwell Á; Thiruthaneeswaran N; Lowe G; Wills R; Sripali S; Hoskin PJ
Brachytherapy; 2016; 15(6):832-838. PubMed ID: 27693171
[TBL] [Abstract][Full Text] [Related]
35. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
[TBL] [Abstract][Full Text] [Related]
36. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?
Greven KM; D'Agostino RB; Lanciano RM; Corn BW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):101-4. PubMed ID: 9747826
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant brachytherapy for endometrial cancer: advantages of the vaginal mold technique.
El Khoury C; Dumas I; Tailleur A; Morice P; Haie-Meder C
Brachytherapy; 2015; 14(1):51-5. PubMed ID: 25183208
[TBL] [Abstract][Full Text] [Related]
38. Time-Driven Activity-Based Costing of CT-Guided vs MR-Guided Prostate SBRT.
Parikh NR; Clark MA; Patel P; Kafka-Peterson K; Zaide L; Ma TM; Steinberg ML; Cao M; Raldow AC; Lamb J; Kishan AU
Appl Radiat Oncol; 2021 Sep; 10(3):33-40. PubMed ID: 34671700
[TBL] [Abstract][Full Text] [Related]
39. MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.
Kamran SC; Manuel MM; Catalano P; Cho L; Damato AL; Lee LJ; Schmidt EJ; Viswanathan AN
Brachytherapy; 2017; 16(6):1159-1168. PubMed ID: 28823395
[TBL] [Abstract][Full Text] [Related]
40. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery.
Lanni T; Keisch M; Shah C; Wobb J; Kestin L; Vicini F
Breast J; 2013; 19(2):162-7. PubMed ID: 23294184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
